1) 2-hydroxy-methyl-3,5,6-trimethyl-pyrazine
2-羟甲基-3,5,6-三甲基吡嗪
1.
OBJECTIVE To prepare an emulsion of 2-hydroxy-methyl-3,5,6-trimethyl-pyrazine palmitate(HTMPP) ,a prodrug of 2-hydroxy-methyl-3,5,6-trimethyl-pyrazine(HTMP) metabolised from tetramethylpyrazine(TMP) and to expect a longer biological half life of HTMPP than that of TMP.
目的研制2-羟甲基-3,5,6-三甲基吡嗪的前药2-羟甲基-3,5,6-三甲基吡嗪棕榈酸酯静脉乳剂,以期延长川芎嗪的生物半衰期。
2) 2-bromomethyl-3,5,6-trimethylpyrazine
2-溴甲基-3,5,6-三甲基吡嗪
3) 2-hydroxy-methyl-3,5,6-trimethyl-pyrazine palmitate
2-羟甲基-3,5,6-三甲基吡嗪棕榈酸酯
1.
OBJECTIVE To prepare an emulsion of 2-hydroxy-methyl-3,5,6-trimethyl-pyrazine palmitate(HTMPP) ,a prodrug of 2-hydroxy-methyl-3,5,6-trimethyl-pyrazine(HTMP) metabolised from tetramethylpyrazine(TMP) and to expect a longer biological half life of HTMPP than that of TMP.
目的研制2-羟甲基-3,5,6-三甲基吡嗪的前药2-羟甲基-3,5,6-三甲基吡嗪棕榈酸酯静脉乳剂,以期延长川芎嗪的生物半衰期。
4) 3,5,6-trimethyl-2-pyrazinecarboxylic acid
3,5,6-三甲基-2-吡嗪甲酸
1.
The mixture of phosphorus oxychloride and pyridine was treated with 3,5,6-trimethyl-2-pyrazinecarboxylic acid resulting in an acylating product which is proved to be 2-pyridinoyl-3,5,6-trimethylpyrazine through the analysis of MS,IR,1H NMR and 13C NMR.
本文报道了一个温和条件下发生的吡啶环α位上的酰化反应,即在室温下,将3,5,6-三甲基-2-吡嗪甲酸(川芎酸)加入到三氯氧磷和吡啶的混合物中,迅速发生反应,产物经MS,IR,1HNMR,13CNMR等谱图表征,为吡啶的α位酰化物。
5) 2-methylpyrazine
2-甲基吡嗪
1.
Study on the synthesis of 2-methylpyrazine;
2-甲基吡嗪的合成工艺改进
2.
The mechanism of 2-cyanopyrazine prepared from 2-methylpyrazine by catalytic ammoxidation was explained qualitatively with the theory of appropriate structure of group.
通过实验得到最优反应条件为:370℃,2-甲基吡嗪、水、氧气、氨气的进料摩尔比为1∶7。
3.
It could be conjectured that 2-methylpyrazine is reacted via a series of dehydrogenations and oxidations to form intermediates pyrazinyl carboxylic acid and pyrazinamide which are then cynadized into 2-cyanopyrazine.
研究2-甲基吡嗪氨氧化催化合成2-氰基吡嗪的催化反应机理后,可知2-甲基吡嗪是通过一系列的脱氢、氧化生成甲醛吡嗪和羧酸吡嗪然后氰化生成产物的,因此优良的催化剂必须由活性及数目合适的脱氢、供[O]及氰化中心组成。
6) 2-Hydroxy-3-(trifluoromethyl)pyridine
2-羟基-3-三氟甲基吡啶
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条